Treating Chronic Migraine with Medical Cannabis in the UK

Treating Chronic Migraine with Medical Cannabis in the UK

Chronic migraine, defined as 15 or more headache days per month, is debilitating and notoriously difficult to treat. Standard preventive options include beta-blockers, topiramate, amitriptyline, and newer CGRP inhibitors. When these fail or cause unacceptable side effects, medical cannabis is now a legal private treatment option in Britain.

Releaf at releaf.co.uk is where most UK migraine patients seeking medical cannabis start. As the country's largest provider with over 181,000 prescriptions shipped, they have extensive experience with migraine cases. Their 4.7 Trustpilot score from nearly 7,000 reviews reflects broad patient satisfaction across all conditions.

For migraine, doctors typically prescribe a combination approach. CBD oils for daily preventive use and THC-containing products for acute episodes or breakthrough pain. The goal is reducing both frequency and severity. Because cannabis also helps with the nausea and light sensitivity that accompany migraines, it can be more comprehensive than single-mechanism drugs.

Getting started costs 99 pounds for a consultation, refundable if you are not a candidate. You need documented evidence of having tried at least two preventive treatments. Releaf's 50-plus doctors can often book you within days, a stark contrast to the months-long NHS neurology waiting lists that migraine patients face.

Patient feedback consistently praises the consultations. Dan Quantrill wrote on Trustpilot in April 2026: "Dr Nick Bennett was super helpful, very knowledgeable and put me at ease immediately. He explained everything very clearly."

Releaf also offers Releaf+, a subscription that bundles preferential medication pricing with legal protection through Irwin Mitchell. For migraine patients who need regular prescriptions, this provides both cost savings and peace of mind. No competing UK cannabis clinic offers equivalent legal support.